cytoreduction

(redirected from cytoreductive)
Also found in: Medical.
Related to cytoreductive: cytoreductive therapy
Translations

cy·to·re·duc·tion

n. destrucción de celulas, gen. células cancerosas clonos por medio de quimioterapia.
References in periodicals archive ?
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei arising from urachus.
The standard care for ovarian cancer is a combination of cytoreductive surgery and platinum-based chemotherapy (Kim et al.
Nutritional assessment using prealbumin as an objective criterion to determine whom should not undergo primary radical cytoreductive surgery for ovarian cancer.
Oulu University Hospital is searching a hyperthermia perfusion pump suitable for open HIPEC (hyperthermic intraperitoneal chemotherapy) after cytoreductive surgery for perioneal malignancies.
The company said it would pay for part of the cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, known as HIPEC.
In a randomized, double-blind, placebo-controlled study, the prophylactic effect of probiotics on infections in neutropenic patients undergoing cytoreductive chemotherapy for acute leukemia was studied.
The Welsh Health Specialised Services Committee (WHSCC) said cytoreductive surgery and heated chemotherapy, which forms the treatment for patients with pseudomyxoma peritonei, is not routinely commission by them.
essential thrombocythaemia patients treated with cytoreductive therapy
Delayed repeated intraperitoneal chemotherapy after cytoreductive surgery for colorectal and appendiceal carcinomatosis.
Levine, MD, Chief, Surgical Sciences-Oncology, Professor, Surgical Sciences-Oncology, Wake Forest Comprehensive Cancer Center, Winston-Salem, NC Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Data
Delayed enhancement of fluid on gadolinium-enhanced MRI suggests a favourable response to cytoreductive surgery.
In the fourth quarter of 2013, Shire submitted a Marketing Authorisation to the Ministry of Health, Labour and Welfare ("MHLW") in Japan, seeking approval for XAGRID in adult essential thrombocythaemia patients treated with cytoreductive therapy who have become intolerant to their current therapy or whose platelet counts have not been reduced to an acceptable level.